CEO
Paul Chaplin
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Loading...
Open
9.15
Mkt cap
2.2B
Volume
2.5K
High
9.19
P/E Ratio
13.50
52-wk high
14.60
Low
9.15
Div yield
N/A
52-wk low
7.89
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.